Across the country, the next generation of researchers is hitting a roadblock just as they begin their scientific journey.
First-year Ph.D. students at institutions like Harvard Medical School are facing an unprecedented crisis due to a federal freeze on $2.2 billion in research grants—a decision initiated by the Trump administration in mid-April. The move has left labs uncertain about their financial futures, and students unsure whether they’ll have the support needed to launch their research careers.
“I’m supposed to be choosing labs, but all of the labs I’m talking to and rotating in have no idea what the funding situation is,”
— Jason Biundo, first-year Ph.D. student in Biological and Biomedical Sciences at Harvard
For students like Jason, the lab selection process is a critical and career-defining step. Yet, with research institutions in limbo, faculty unable to commit, and budgets hanging in the balance, students and postdocs alike are left scrambling for mentors, lab space, and salary support.
⚠️ A Threat to the Nation’s Innovation Ecosystem
This freeze doesn’t just impact students—it threatens the entire biomedical research pipeline. Graduate students and postdocs are the backbone of the country’s innovation engine. They fuel medical discoveries, drive clinical research, and develop the next generation of life-saving therapies.
By cutting off access to funding and resources, the federal government is disrupting decades of investment in science and health, jeopardizing progress in cancer research, infectious diseases, mental health, and more.
🏛️ Legal Action and a Fight for Scientific Freedom
In response, Harvard University has filed suit, asserting that the government’s actions violate both federal law and the university’s First Amendment rights. This legal battle may set an important precedent in protecting academic freedom and ensuring stability for scientific advancement.
